Stretch affects phenotype and proliferation of vascular smooth muscle cells |
| |
Authors: | Konstantin G. Birukov Vladimir P. Shirinsky Olga V. Stepanova Vsevolod A. Tkachuk Alfred W. A. Hahn Terese J. Resink Vladimir N. Smirnov |
| |
Affiliation: | (1) Department of Biochemistry and Molecular Biology, University of Massachusetts Medical School, 55 Lake Avenue North, 01655 Worcester, Massachusetts, USA |
| |
Abstract: | The focus of this study was to identify the molecular basis for the hypersensitive response of glycogen phosphorylase activation to epinephrine stimulation in alloxan diabetic-derived cardiomyocytes. Cyclic AMP levels were found not to be significantly different between normal and diabetic-derived cells while cGMP concentrations were found consistently to be significantly lower in diabetic-derived cells than in normal cells. Treatment with cyclic GMP analogues did not affect phosphorylase activation by epinephrine in normal cardiomyocytes whereas, IBMX, a nonselective phosphodiesterase inhibitor, had a significant effect on basal and agonist-stimulated phosphorylase activity in both normal and diabetic-derived cardiomyocytes. Differences in the time course for the rate of decay of phosphorylasea from agonist-stimulated to basal levels were observed between normal and diabetic cells. After 3 h in primary culture, phosphorylasea activity returned to basal levels more quickly in normal than in diabetic-derived cells while after 24 h in culture, the time for phosphorylasea decay was not significantly different between normal and diabetic myocytes and was longer than the 3 h response. After 3 h in primary culture, no significant difference in phosphorylase kinase activity was observed between normal and diabetic-derived cells exposed to epinephrine whereas, after 24 h in culture, phosphorylase kinase activity was significantly decreased in diabetic cells under basal and agonist-stimulated conditions. These data collectively suggest that the hypersensitive response of glycogen phosphorylase to epinephrine stimulation in diabetic-derived cardiomyocytes is not due to a defect present at the level of phosphorylase kinase but may, in part, result from an alteration in cardiac phosphodiesterase activity resulting from diminished intracellular cyclic GMP concentrations. |
| |
Keywords: | glycogen phosphorylase alloxan-diabetes cardiomyocytes cGMP phosphodiesterase |
本文献已被 SpringerLink 等数据库收录! |
|